Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Oracle Shares Plunge as Analyst Delivers Scathing Assessment

Dieter Jaworski by Dieter Jaworski
September 27, 2025
in Analysis, Mergers & Acquisitions, Nasdaq, Tech & Software
0
Oracle Stock
0
SHARES
107
VIEWS
Share on FacebookShare on Twitter

Oracle Corporation finds itself in a steep decline, with its stock extending losses for a fourth consecutive session. The downturn follows a severe analyst critique questioning the company’s valuation, though a potential deal involving TikTok’s US operations offers a contrasting glimmer of hope.

Widespread Skepticism Weighs on Tech Giant

The selling pressure intensified after analysts at Rothschild Redburn initiated coverage on Oracle with a stark “Sell” recommendation. The firm issued a price target of just $175, a figure substantially below the stock’s current trading level. This pessimistic outlook is rooted in the belief that the market is overestimating the revenue potential and growth of Oracle’s cloud computing division.

This bearish sentiment is compounded by a broader shift in investor attitude toward AI-related stocks. The initial euphoria surrounding artificial intelligence is being replaced by a more critical examination of profitable business models and tangible returns. This trend was evident on Thursday when Oracle’s stock dropped 5.6%.

Key Points of Concern:
* The equity fell an additional 2.7% on Friday.
* The stock has now declined for four straight days.
* Rothschild’s $175 price target highlights fears of overvaluation.
* Apprehension surrounds the sustainability of cloud revenue growth.

Should investors sell immediately? Or is it worth buying Oracle?

Potential TikTok Partnership Offers a Contrasting Narrative

Amid the negative momentum, Oracle’s involvement in a high-profile deal presents a potential counterweight. The company is positioned to become the key cloud infrastructure and security provider for the US operations of TikTok. A consortium of American investors, which includes Oracle, is reportedly set to acquire a 45% stake in a newly formed entity that would oversee the popular video app’s activities in the United States.

However, significant uncertainty clouds this prospect. The transaction still awaits crucial approval from Chinese regulators. Whether this partnership can ultimately reverse Oracle’s current weak performance remains an open question.

A Divided Wall Street

The analyst community appears deeply split on Oracle’s true value, reflecting the overall market uncertainty. While Rothschild Redburn advocates selling the shares, Bernstein Research maintains a bullish “Outperform” rating. Bernstein’s contrasting price target of $364 presents a dramatic divergence from the negative assessment, underscoring the lack of consensus on the technology company’s appropriate market valuation.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from February 8 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Oracle: Buy or sell? Read more here...

Tags: Oracle
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

February 8, 2026
DroneShield Stock
Analysis

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock
Analysis

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Next Post
Ocugen Stock

Ocugen Shares Retreat Despite Upbeat Pipeline Updates

Alibaba Stock

Alibaba's AI Ambitions Meet Market Reality as Shares Pull Back

ASML Stock

ASML's AI Partnership Ignites Stock Rally

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com